Patients Deep Dive: Patients & Partnerships 2024 IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
